Amgen Inc is close to buying Onyx Pharmaceuticals Inc for $125 per share, or more than $10 billion, in a deal that is expected to be announced as soon as Monday, two people familiar with the matter said on Saturday.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment